- CFO Spotlights
- Profiles
- Charles Carter
Profile
Charles Carter
Chief Financial Officer, principal financial officer, principal accounting officer and secretary, Ovid Therapeutics Inc.
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Charles Carter has been Chief Financial Officer, principal financial officer, principal accounting officer and secretary of Ovid Therapeutics Inc. since July 6, 2026, according to the company's filing of July 8, 2026.1
The filing gives Charles Carter's previous role as Senior Vice President of Finance and Financial Planning at Ovid Therapeutics Inc.1 Charles Carter already worked at Ovid Therapeutics Inc. when appointed, so the record counts the move as an internal promotion.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Ovid Therapeutics Inc. (OVID) Pharmaceutical Preparations | Chief Financial Officer, principal financial officer, principal accounting officer and secretary | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- July 6, 2026effective
Ovid Therapeutics Inc. appointed Charles Carter as Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective July 6, 2026. Profile of Jeffrey Rona.
the Company’s Board of Directors (the “Board”) appointed Charles Carter, the Company’s Senior Vice President of Finance and Financial Planning, as the Company’s Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective as of the Separation Date.
[1] Filing by Ovid Therapeutics Inc., filed with the SEC on July 8, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Current report filed with the SEC, Ovid Therapeutics Inc.. U.S. Securities and Exchange Commission, EDGAR, filed July 8, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Charles Carter wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.